More Business Wire
View Older Stories View Newer Stories-
Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome
-
Fairbanks Morse Defense Expands Robotic Welding Capabilities to Strengthen Fleet Readiness and Reduce Maintenance Downtime
-
Junevity Announces First Peer-Reviewed Research Showing Single-Target Repression Can Reprogram Cellular Aging
-
32nd Annual Venture Capital & Private Equity Conference at Harvard Business School Announces Speakers and Agenda
-
National CineMedia Launches 2026 US Young Lions Competition
-
Adam Yale Joins First Manhattan as Portfolio Manager, Based in Omaha
-
Miro Launches Collaborative AI Workflows to Transform How Teams Work and Accelerate Innovation
-
CQL Launches POS360° to Unify Online & In-Store Data between Shopify POS and Bloomreach
-
Riskified Analysis Reveals 1 in 4 Refund Dollars Is Abusive; Introduces "Dynamic Returns," a New Policy Protect Feature, to Safeguard Revenue While Increasing Customer Satisfaction
-
Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation
-
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
-
Amphenol Completes Acquisition of CCS Business From CommScope
-
Sole Source Capital Acquires Brite, a Cybersecurity & Managed Services Provider
-
Tamboran Appoints Mr. Todd Abbott as Chief Executive Officer
-
Atlantic Alumina Announces $450 Million Strategic Partnership with United States Government to Secure U.S. Alumina Production and Build America’s First Large Scale Primary Gallium Production Circuit
-
Wilmington PharmaTech Appoints Seasoned Commercial Leader to Drive Growth
-
Pagaya to Participate in Upcoming Investor Conferences and Events
-
HighPost Capital Promotes David Weston to Senior Managing Director
-
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
-
The ONE Group Reports Preliminary Fourth Quarter and Full Year 2025 Sales Results
-
PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study Evaluating Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia
-
Hummingbird Diagnostics Names Vincent Lozada Chief Executive Officer
-
American Eagle Outfitters Reports Record Holiday Sales
-
Curi Bio Launches Asia-Pacific Hub, Delivering Greater Support to its Growing APAC Business
-
Sleep Number Introduces ComfortMode™ Mattress: Premium Comfort at an Affordable Price
-
o9 Expands Its Next-Generation Category Management Solution for Grocery Retail
-
Offerpad Solutions Inc. Announces Pricing of $18 Million Registered Direct Offering
-
Dispatch Bio Announces FDA Clearance of IND Application for DISP-10, a First-in-Class Immunotherapy Treatment, in Solid Tumors
-
Manas AI Secures Strategic Advantage through Unique Deep Integration with Schrödinger’s Physics + AI Discovery Platform
-
U.S. FDA Grants RMAT Designation to ECT204, an ARTEMIS® CAR (AbTCR) T-Cell Therapy for Advanced Hepatocellular Carcinoma
-
BitGo Holdings Announces Launch of Initial Public Offering
-
Jumpmind CX Connect Modernizes Retail Checkout, Integrating Payments into Interactive Customer Displays
-
Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus
-
ConcertAI and Foundation Medicine Integrate Genomic and Clinical Data to Transform Translational Research and Efficient Drug Development
-
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
-
Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors
-
TRAY Introduces AI Intelligence Suite to Transform How Restaurants Analyze, Plan, and Operate
-
SmartSense by Digi Launches SmartSense ONE at NRF 2026
-
Masco Corporation Announces Date for Earnings Release and Conference Call for 2025 Fourth Quarter and Full Year
-
VelaFi Raises $20M Series B to Expand Global Stablecoin Infrastructure
-
Sonesta Appoints Keith Pierce and Jeff Leer as Co-Chief Executive Officers Effective April 1, 2026
-
Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones
-
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
-
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow
-
Forum Energy Technologies Announces Appointment of The Honorable Leslie A. Beyer to its Board of Directors
-
Improving Physical Health Tops Americans’ 2026 Resolutions, with Finances a Close Second, Northerner Survey Finds
-
Horace Mann to announce fourth-quarter and full-year 2025 financial results on February 3
-
CommScope Completes Divestiture of Connectivity and Cable Solutions Segment and Rebrands Parent Company
-
Collision Partners Completes First Acquisitions, Launches Quality-First Growth Strategy
-
Truvian Health Rapidly Expands TruVerus™ Menu with FDA Clearances for Cardiovascular, Liver, and Core Metabolic Health Tests
